Neuromod Devices' Lenire, a bimodal neuromodulation device, has received De Novo approval from the FDA to treat tinnitus. According to the company, Lenire is the first of its kind to receive FDA approval.
After 20 years searching for a cure for tinnitus, researchers at the University of Auckland are excited by ‘encouraging results’ from a clinical trial of a mobile-phone-based therapy, according to an article on the University's website.
Australian author and academic David Tuffley challenges bold claims that a neuroprosthetic device developed by Elon Musk's Neuralink start-up company could “cure tinnitus” within five years, in an article on “The Conversation” website.
With this year’s return of cicadas, many will view the mostly harmless insects as an annoyance. However, the bugs’ high-pitched buzzing sound — which can be loud enough to drown out a jet plane flying overhead — could potentially worsen tinnitus.
While tinnitus has no known cure, one science-based app, Diapason, can help offer relief to some of the 50 million people suffering in the US. Beginning on World Hearing Day, March 3, Diapason announced that it will offer $25,000 worth of free subscriptions during March.
Medical device company, Neuromod Devices Ltd, announced that it has launched Ótologie, a “specialist telehealth service for tinnitus.” This new service will provide tinnitus patients, throughout the United Kingdom and Europe, with a private care option to avoid waiting lists and give them immediate access to treatment from its telehealth service.